• Aging Liver Stress Under Alcohol and ART Exposure

  2026-09-20

  Chen and colleagues show that hepatocyte senescence and advanced age amplify endoplasmic reticulum stress, metabolic disruption, and liver injury caused by alcohol, ritonavir, lopinavir, and hippuric acid. The study’s value lies in combining senescent liver-cell models with young-versus-aged mice to identify stress-response changes that are less apparent in non-senescent systems.

• Doxycycline Hyclate in MMP-2/9 BBB Research

  2026-09-19

  Doxycycline hyclate is a practical matrix metalloproteinases inhibitor for connecting MMP-2/MMP-9 activity with blood-brain barrier integrity, neuronal apoptosis, and inflammatory vascular injury. This workflow translates a mouse arsenic-neurotoxicity study into reproducible assay design, dosing controls, solubility handling, and cross-domain applications.

• Gamithromycin PK/PD Cutoffs in Piglets

  2026-09-18

  Zhou et al. integrated susceptibility distributions, serum-modified pharmacodynamics, ex vivo exposure–response analysis, and Monte Carlo simulation to define Gamithromycin cutoffs for Haemophilus parasuis in piglets. The study linked AUC24h/MIC targets to dose adequacy, showing that the marketed 6 mg/kg regimen approached but did not reach a 90% probability of target attainment for all modeled isolates.

• CD28–ARS2–PKM Splicing in CD8+ T Cells

  2026-09-18

  The 2024 study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and gives activated CD8+ T cells greater flexibility in glucose catabolism. Its findings connect nuclear RNA-processing control with PKM2-dependent cytokine production and antitumor activity, while also defining a CD28 mechanism that operates independently of PI3K activation.

• Gamithromycin PK/PD Workflows for Respiratory Models

  2026-09-17

  Gamithromycin enables respiratory infection studies that connect serum susceptibility, lung exposure, and AUC24h/MIC rather than relying on broth MIC alone. This workflow translates evidence from Haemophilus parasuis research into practical assay design, formulation control, and troubleshooting for veterinary pharmacology teams.

• Rapid Recombinant Annexin V Purification: Study Insights

  2026-09-17

  Burger and colleagues introduced a streamlined purification strategy for recombinant annexin V that combines mild osmotic cell opening, reversible calcium-dependent liposome binding, and final ion-exchange chromatography. The resulting workflow produced protein suitable for demanding structural and electrophysiological studies while reducing co-purification of bacterial contaminants.

• Tigecycline for CREC Assay Design

  2026-09-16

  Tigecycline provides a ribosome-targeting, bacteriostatic readout for studying resistant Enterobacter cloacae alongside carbapenemase and plasmid-transmission data. This guide translates hospital surveillance findings into practical MIC, time-course, and genotype–phenotype workflows while highlighting controls, storage, and interpretation limits.

• GS967 and the Aging Heart: A Causal Assay Strategy

  2026-09-16

  GS967 is a cardiac late sodium current inhibitor for testing how pathological Na+ influx links Nav1.5 regulation to repolarization, calcium handling, and diastolic dysfunction. This article develops a mechanistic assay strategy that complements, rather than repeats, standard electrophysiology workflows.

• Tacrolimus (FK506) in Stress-Immune Assays

  2026-09-15

  Tacrolimus (FK506) is more than a calcineurin inhibitor: it can serve as a precise immune perturbation within stress-aware assay designs. This article connects FK506 pharmacology with AMPK–SQSTM1–NRF2 biology while separating established evidence from exploratory applications.

• ABT-888 (Veliparib) Experimental Workflow

  2026-09-15

  ABT-888 (Veliparib) enables controlled studies of PARP1/2-dependent DNA repair inhibition, chemotherapy sensitization, and radiation response. This workflow connects established colorectal cancer research with biomarker-led experiments in PARP-resistant ovarian cancer models, while separating reported evidence from practical assay recommendations.

• Tigecycline Workflows for MDR Research

  2026-09-14

  Tigecycline provides a practical glycylcycline antibiotic workflow for susceptibility testing, resistant-pathogen phenotyping, and transmission studies. This guide connects 30S-targeted activity with plasmid-focused CREC assays, offering executable conditions and troubleshooting strategies for reproducible research.

• WSP-5 for Live-Cell H2S Imaging

  2026-09-14

  WSP-5, also called Washington State Probe-5, is a turn-on fluorescent probe for rapid H2S detection in biological systems. Its reported fast activation, green-shifted fluorescence, and compatibility with live-cell imaging support monitoring H2S dynamics in cells, while disease-model interpretation requires independent controls and calibration.

• Cinoxacin Workflows for Gram-Negative Research

  2026-09-13

  Build reproducible Cinoxacin assays for susceptibility testing, urinary tract infection research, and resistance profiling with concentration ranges matched to the compound’s documented activity. The workflow also shows how a precision-trial concept—time above a predefined biological threshold—can improve interpretation without confusing immunology evidence with direct antibacterial validation.

• MDockPeP2_VS: Screening Peptides Against TEM-1

  2026-09-12

  The PNAS Nexus study introduces MDockPeP2_VS, a structure-based workflow that combines molecular docking with conservation between protein folding and protein–peptide binding to make large-scale peptide screening more practical. Applied to Escherichia coli TEM-1 β-lactamase, the approach identified TF7 as a micromolar inhibitor, providing a computational starting point for β-lactam antibiotic resistance research and follow-up biochemical validation.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-09-12

  A Frontiers in Endocrinology study links elevated QPRT, a rate-limiting enzyme in de novo NAD+ synthesis, to breast cancer migration and invasion through a purinergic signaling–myosin light chain axis. Its paired genetic and pharmacological experiments provide a useful framework for testing how metabolic remodeling influences cytoskeletal behavior, while also highlighting limits in assigning direct P2Y11 receptor causality.

8460 records 1/564 page Next 12345 下5页 Last page